Medicus Pharma Common Stock Statistics
Share Statistics
Medicus Pharma Common Stock has -
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,529 |
| FTD / Avg. Volume | 5.22% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -2.2 and the forward
PE ratio is null.
Medicus Pharma Common Stock's PEG ratio is
0.08.
| PE Ratio | -2.2 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 7.46 |
| P/FCF Ratio | -2.28 |
| PEG Ratio | 0.08 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Medicus Pharma Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33,
with a Debt / Equity ratio of 0.1.
| Current Ratio | 2.33 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.1 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.03 |
| Interest Coverage | -35.21 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 5.56, so Medicus Pharma Common Stock's
price volatility has been higher than the market average.
| Beta | 5.56 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 57.14 |
| Average Volume (20 Days) | 67,670 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.18M |
| Net Income | -10.62M |
| EBITDA | -10.62M |
| EBIT | -10.25M |
| Earnings Per Share (EPS) | -1.1 |
Full Income StatementBalance Sheet
The company has 4.16M in cash and 322.27K in
debt, giving a net cash position of 3.84M.
| Cash & Cash Equivalents | 4.16M |
| Total Debt | 322.27K |
| Net Cash | 3.84M |
| Retained Earnings | -28.9M |
| Total Assets | 5.65M |
| Working Capital | 3.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -10.25M
and capital expenditures 0, giving a free cash flow of -10.25M.
| Operating Cash Flow | -10.25M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.25M |
| FCF Per Share | -1.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
